SecBot SecBot
6-K ·Filed Oct 21, 2026

NIVF

NewGenIvf Group Ltd
NEUTRAL
Impact 4/10
Horizondays Processed5d 20h ago SEC0001213900-26-111191
Notable filing: 6-K
Actionable Insight • Neutral

Monitor for any Nasdaq compliance notice or further capital structure actions (e.g., convertible note exercises) that could affect post-split share count. The split itself is administrative and does not alter the company's operational outlook.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+1d
NIVF ▼ -20.97% at T+1d
NEUTRAL call -20.97% · α vs SPY -19.79% · entry $0.1884 → $0.1489
Next anchor: T+5d tomorrow
Latest observation: T+2 +28.37% FF3 residual α
Entry = T+0 close
Oct 21, 2026
via day close
T+1d
-20.97%
call -20.97% · α -19.79%
$0.1489
settled 5d ago
T+5d
Pending
tomorrow
T+20d
Pending
in 22d
T+60d
Pending
in 3mo

Price Chart

Loading chart...

Executive Summary

NewGenIvf Group Ltd announced a 1-for-8 reverse stock split approved by the Board on October 6, 2026, effective October 23, 2026. The split reduces outstanding Class A shares from ~9.8M to ~1.2M and adjusts all convertible securities proportionally. This is a routine capital structure adjustment, likely aimed at maintaining Nasdaq listing compliance, with no fundamental business change.

Key Facts

  • Reverse stock split ratio: 1-for-8, effective October 23, 2026.
  • Outstanding Class A shares expected to reduce from ~9,821,197 to ~1,227,650.
  • No fractional shares issued; full share granted for fractional entitlements.
  • All options, warrants, and convertible securities adjusted by dividing exercise/conversion shares by 8.
  • No shareholder vote required; authorized share count remains unlimited.
  • Ticker symbol NIVF unchanged; new CUSIP G0544E162.

Financial Impact

No financial impact; reverse split is a mechanical share consolidation with no change to market capitalization or business fundamentals.

share countCUSIP

Risk Factors

  • Post-split share price may be volatile due to low liquidity and small float.
  • Potential for further dilution if convertible notes are exercised before the record date.

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001213900-26-111191
Document: 0001213900-26-111191-index-headers.html0001213900-26-111191
Document: 0001213900-26-111191-index.html0001213900-26-111191
Document: 0001213900-26-111191.txt0001213900-26-111191
22 reports for NIVF
Performance horizon
75% Hit rate @ T+1 9 of 12 directional calls Went positive at some point 10 of 12 best @ T+60▲ +98.51%Jul 31, 2026
Filters
Rows
Reports for NIVF — sortable, filterable
TypeNow
Oct 21, 2026
5d ago
6-K
NEUTRAL ★ 4/10
$0.1884 $0.1489▼ −20.97%▼ −19.79%$1.16 (+515.71%)
Oct 7, 2026
19d ago
6-K
BEARISH ★ 7/10
$0.0811 $0.0721▲ +11.10%▲ +11.70%$1.16 (−1330.33%)
Oct 7, 2026
19d ago
6-K
NEUTRAL ★ 3/10
$0.1060 $0.0811▼ −23.49%▼ −23.07%$1.16 (+994.34%)
Oct 6, 2026
20d ago
SC 13D/A
NEUTRAL ★ 3/10
$0.0987 $0.1060▲ +7.40%▲ +7.64%$1.16 (+1075.28%)
Oct 5, 2026
21d ago
6-K
BEARISH ★ 6/10
$0.1100 $0.0987▲ +10.27%▲ +10.82%$1.16 (−954.55%)
Sep 30, 2026
26d ago
Press Release
BEARISH ★ 6/10
$0.1680 $0.1010▲ +39.88%▲ +40.06%$1.16 (−590.48%)
Sep 30, 2026
26d ago
424B4
BEARISH ★ 8/10
$5.38 $3.23▲ +39.88%▲ +40.06%$1.16 (+78.42%)
Sep 29, 2026
28d ago
EFFECT
BEARISH ★ 7/10
$0.0720 $0.1680▼ −133.33%▼ −133.54%$1.16 (−1511.11%)
Sep 28, 2026
28d ago
Press Release
BEARISH ★ 6/10
$0.0720 $0.1680▼ −133.33%▼ −133.54%$1.16 (−1511.11%)
Sep 2, 2026
7w ago
Insider Cluster
MIXED ★ 6/10
$1.21 $1.18▼ −2.48%▼ −3.53%$1.16 (−4.13%)
Showing 10 of 22

US Market Status

Market Closed — Opens in 4h 56m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 21, 2026